The effect of short‐term remote ischemic preconditioning on endothelial function of patients with chronic kidney disease: A randomized pilot study
Nephrology · 2024
DOI: 10.1111/nep.14282 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nephrology, 2024. Verfasst von Xieguanxuan Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese PLA, Beijing, China. Hauptthemen laut MEDLINE: Ischemic Preconditioning, Renal Insufficiency, Chronic, Endothelium, Vascular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aim
Patients with chronic kidney disease (CKD) are more susceptible to endothelial dysfunction and cardiovascular disease (CV). Remote ischemic preconditioning (rIPC) has been proven efficient in improving endothelial function and lowering the risk of CV. However, the safety and effect of rIPC on endothelial function in patients with CKD have not been effectively assessed.
Methods
45 patients with CKD (average estimated glomerular filtration rate: 48.4 mL/min/1.73 m 2 ) were randomly allocated to either 7‐day daily upper‐arm rIPC (4 × 5 min 200 mmHg, interspaced by 5‐min reperfusion) or control (4 × 5 min 60 mmHg, interspaced by 5‐min reperfusion). Vascular endothelial function was assessed by natural log–transformed reactive hyperemia index (LnRHI) before and after a 7‐day intervention. Arterial elasticity was assessed by augmentation index (AI).
Results
The results showed that LnRHI could be improved by rIPC treatment (Pre = 0.57 ± 0.04 vs. Post = 0.67 ± 0.04, p = .001) with no changes relative to control (Pre = 0.68 ± 0.06 vs. Post = 0.64 ± 0.05, p = .470). Compared with the control group, the improvement of LnRHI was greater after rIPC treatment (rIPC vs. Control: 0.10 ± 0.03 vs. −0.04 ± 0.06, between‐group mean difference, −0.15 [95% CI, −0.27 to −0.02], p = .027), while there was no significant difference in the change of AI@75 bpm ( p = .312) between the two groups.
Conclusion
RIPC is safe and well tolerated in patients with CKD. This pilot study suggests that rIPC seems to have the potential therapeutic effect to improve endothelial function. Of note, further larger trials are still warranted to confirm the efficacy of rIPC in improving endothelial function in CKD patients. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School of Chinese PLA, Beijing, China.
- Department of Nephrology, The First Medical Centre, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beij…
- School of Medicine, Nankai University, Tianjin, China.
ORCID-Profile: Xieguanxuan Xu, Guangyan Cai
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, X., Zhang, Y., Chen, Y., Yang, C., Guo, X., Zhang, Q., Li, Y., Wu, J., Cao, X., Chen, X., & Cai, G. (2024). The effect of short‐term remote ischemic preconditioning on endothelial function of patients with chronic kidney disease: A randomized pilot study. Nephrology. https://doi.org/10.1111/nep.14282
Vancouver
Xu X, Zhang Y, Chen Y, Yang C, Guo X, Zhang Q, et al. The effect of short‐term remote ischemic preconditioning on endothelial function of patients with chronic kidney disease: A randomized pilot study. Nephrology. 2024. doi:10.1111/nep.14282
BibTeX
@article{Xu2024,
author = {Xu, Xieguanxuan and Zhang, Yu and Chen, Yuhao and Yang, Chen and Guo, Xinru and Zhang, Qiuyue and Li, Yisha and Wu, Jie and Cao, Xueying and Chen, XiangMei and Cai, Guangyan},
title = {The effect of short‐term remote ischemic preconditioning on endothelial function of patients with chronic kidney disease: A randomized pilot study},
journal = {Nephrology},
year = {2024},
doi = {10.1111/nep.14282}
}
EUVIMED